Drawing on our 18 years’ of experience in the sector, SMi proudly presents the inaugural Superbugs & Superdrugs USA Conference & Exhibition in New Jersey, November!
The recent rare superbug outbreak in Wisconsin* which is now blamed for the deaths of 18 people has rendered the attention amongst superbug and superdrug professionals again. Despite advanced healthcare and antibiotics, more than 100,00 people die from hospital-acquired infections per year, which equates to 4% of patient populations in the US. Scientists now have to gear to combat on resistance to antimicrobials, implant-related resistant infections and mutation of bacterial. A recent study** stated that bacterial wall ‘gates’ could lead to new anti-superbug drugs. As such, SMi is excited to extend our premier Superbugs & Superdrugs conference to the US this November, providing a timely platform for both pharmaceutical and healthcare experts to share their research updates and insights in this subject – driving the rebuild of a global defensive wall of bacteria!
Registration is now live for this unmissable event. Visit http://www.superbugs-usa.com/bentham for more information.